Salt Composition in both
Salt Composition
Esomeprazole 40mg(same for both)
You Searched
Strip of 14 tablets
We only sell the best substitute from top brands
Our Recommendation
Esopen 40mg Tablet 10s
Strip of 10 tablets
472+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
coreulenceWe are here to helpIf you miss a dose of our medicineWe willrilizing Sildenafil (Sildenafil) TreatmentOrlistat (Xatral brands) TreatmentCheaper XENO 30 Tablet TreatmentLiraglioside Acclatable Mes factor Device 1s
osstatin8 manufacturersManufactured by GSKWe are here to support youIf you need help covering everythingNow Press 1 –/8 to Skip the jump to Skip the jump to Skip the jump to Skip the jump to Skip the jump to Skip the jump to Skip the jump to Skip the jumpDon't feel like you have to explain every detail to us?Our free consultation plus our free product review is always recommended to help us get this treatment done sooner.
New Jersey-based Prilosec, which has been in the news for selling its “Heartburn and Acid Reflux Medication” online for $1,100 per month, is launching a new deal that will allow consumers to buy the medication off-patent in New Jersey and around the world. The move follows a similar deal in the United States. Prilosec has received major international media attention and is expected to earn $1,000 per month for the first time since 2010.
The new deal follows another deal by Pfizer in the United States for the purchase of Prilosec’s heartburn and acid reflux medication Nexium (esomeprazole). Nexium is a prescription drug used to treat conditions like asthma, chronic obstructive pulmonary disease (COPD), and chronic heartburn. The drug is available by prescription only and is not covered by insurance.
Pfizer’s acquisition of Prilosec has brought the price of Prilosec to nearly $1,000 per month. This was the second new deal by Prilosec to focus on the heartburn and acid reflux medication market.
Pfizer will also be purchasing its own generic version of Nexium from Novartis for $5 per tablet. Nexium was a popular heartburn medication for years and was a major selling point for Pfizer.
The new deal follows a similar transaction by Teva Pharmaceuticals for the purchase of Prilosec’s acid reflux medication Nexium (esomeprazole). Nexium is also a prescription acid blocker medication that is used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and acid reflux.
“The introduction of Prilosec’s generic product range allows us to focus on expanding our product portfolio to include generic medications,” said Tom R. Denton, CEO of Prilosec. “We look forward to the potential of this acquisition to continue the growth of Prilosec’s portfolio of generic medicines.”
Prilosec has not yet signed a new agreement with Novartis.
The deal follows a similar transaction by Merck & Co., which is looking to buy Merck’s generic version of Pfizer’s heartburn and acid reflux medication Nexium (esomeprazole).
The deal also follows the purchase of a number of other companies including Sun Pharmaceuticals, which has a global presence in the heartburn and acid reflux medication market. Sun will manufacture and supply Nexium and its generic equivalent, Prilosec, in its global portfolio.
As of late, the companies have agreed to terms and conditions in regard to the proposed purchase of Prilosec’s generic and Nexium-based product range.
•Nexium is an acid-reflux medication that works by blocking stomach acid production and by increasing stomach acid production. Nexium, a type of medicine known as an H2 antagonist, is an H2-receptor agonist that helps relieve symptoms of acid reflux. It helps heal acid reflux and lower the likelihood of heartburn, ulcers, and other conditions that are caused by excessive stomach acid.
Nexium is available in both brand-name and generic versions. The brand-name version is manufactured by Teva Pharmaceutical Industries, and the generic version is a more affordable alternative to Nexium. The two versions are intended to be sold over the counter.
Prilosec’s Nexium (esomeprazole) is a prescription drug that is used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and acid reflux. Prilosec’s is also a treatment option for chronic heartburn and GERD.
In addition to Nexium, Prilosec is expected to earn an additional $1,100 per month through the sale of Prilosec’s generic product range.
Prilosec contains a combination of active ingredients esomeprazole 20 mg and omeprazole 40 mg.
The global Nexium (esomeprazole) market size was valued at USD 3.4 Billion in 2024 and is forecasted to reach USD 4.7 Billion by 2033, growing at a CAGR of 2.2% during the forecast period from 2024 to 2033. This growing market is projected to be the largest market for Nexium for the next 5 years, owing to several factors, including the increasing demand for Nexium and its growing market share, a growing number of emerging players, and increasing disposable income.
Nexium sales for the 2023 timeframe were up 21% from 2022 to 2033, indicating a growth rate of 21.4% in 2024, driven by the launch of Nexium in the US market. In 2023, Nexium sales for the current year accounted for a significant share of the global Nexium market revenue, with a growth rate of 9.6% in 2024, reflecting a surge in demand for Nexium and its active ingredient esomeprazole magnesium.
The growth of the global Nexium market is supported by the increasing prevalence of gastroesophageal reflux disease (GERD), which is a condition characterized by the overgrowth of the esophagus and associated symptoms such as regurgitation and esophagitis. Additionally, the increasing prevalence of GERD in the US and European Union countries and the emergence of a broader awareness campaign and healthcare infrastructure contribute to an increased demand for Nexium, which is expected to drive significant growth.
Furthermore, the rising prevalence of chronic conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis have further driven the demand for Nexium, with a high share of the global market. However, the increasing prevalence of GERD and the growing demand for Nexium have contributed to a growing market share of the global market, which is expected to grow at a CAGR of 2.3% during the forecast period.
According to market research conducted by the CAGR Global Market Insights Institute (CGI), Nexium sales reached USD 3.4 Billion in 2024, representing a 5.1% growth rate and an 8.5% share of global Nexium sales revenue. The market for Nexium is expected to reach USD 4.7 Billion by 2033, growing at a CAGR of 2.2% during the forecast period, driven by the launch of the drug in the US market and its increasing prevalence of GERD. The rise in the incidence and prevalence of chronic conditions is a major driver for the global Nexium market.
The ongoing expansion of Nexium's market is expected to lead to an increased demand for Nexium, which is expected to continue its growing role in the global Nexium market by driving the demand for its active ingredient esomeprazole magnesium. The rising prevalence of GERD and the growing demand for Nexium are significant drivers for the global market, which is projected to grow at a CAGR of 2.5% during the forecast period.
According to the CAGR Global Market Insights Institute, Nexium sales in 2024 accounted for a market share of 9.6% in 2024, reflecting a 3.6% growth rate and a 7.3% share of global Nexium sales revenue. The growth of the global market is supported by the increasing prevalence of GERD and the rising demand for Nexium. The increasing prevalence of GERD and the growing demand for Nexium are significant drivers for the global market.
The rising incidence and prevalence of chronic conditions is a significant driver for the global market, which is expected to grow at a CAGR of 2.5% during the forecast period. The increasing prevalence of chronic conditions and the growing demand for Nexium are significant drivers for the global market. The rising demand for Nexium, which is expected to continue its growth in the global Nexium market, is expected to drive the demand for Nexium.
The demand for Nexium is a significant driver for the global market, which is expected to grow at a CAGR of 2.2% during the forecast period, driven by the rising prevalence of GERD and the growing demand for Nexium.
In addition to the increased prevalence of GERD and the growing demand for Nexium, the increasing number of prescription drugs and the rising incidence of chronic conditions are significant drivers for the global market.
Nexium Control 20mg Gastro-Resistant Tablets treats heartburn and acid reflux. They are suitable for short-term use of occasional heartburn sufferers. The active ingredient of the tablets is responsible for reducing stomach contents, and esomePhencyhone capsules are suitable for daily use. The absorption of the protective tablets is not affected by food, and the drug enters the digestive tract mainly by the stomach, making the protection the main route of digestion. This tablet is well tolerated, and the effect persists for up to 10 days. The tablets are manufactured in different batches and contain different strengths and volumes of ingredients. This tablet is intended for use as a proton pump inhibitor (PPI) only tablet and is not used in patients suffering from heartburn. It is not meant for use by individuals suffering from stomach ulcers and other stomach disorders. It is not expected to treat the following conditions in adults, and therefore, patients with these conditions are recommended to consult with their doctor before taking the medicine.
Nexium Control 20mg Gastro-Resistant Tablets20 Tablets
In StockNexium Control 20mg Gastro-Resistant Tablets is a proton pump inhibitor (PPI) containing a combination of ingredients, namely,:
You can buy Nexium Control 20mg Gastro-Resistant Tablets online from Reliance Industries. Reliance Industries is one of the leading manufacturers of generic Nexium Control 20mg Gastro-Resistant Tablets, which is known for its high-quality and excellent quality. We are proud to be the first company to make the process as pain-free as possible.
The NEXIUM tablets are designed to be taken as an immediate release form in a tablet, such as in the form of a tablet or capsule. This allows you to take them when you need them to help you heal your period.
Nexium is used to treat conditions such as:
• Heart disease • Heart failure • Heart attack • Heart valve disease • Kidney disease • Liver disease • Stroke • Stroke associated diseases • Liver disease • Multiple sclerosis
The tablets contain 20 mg of the active ingredient esomeprazole, a proton pump inhibitor.
The tablet should be swallowed whole with a full glass of water.
The NEXIUM tablets contain 20 mg of the active ingredient proton pump inhibitor.
The tablets should be swallowed whole with a full glass of water.
Nexium tablets are available in doses of 20 mg, 40 mg, and 80 mg.
For patients with mild to moderate pain in the upper arm or lower back, the tablets should be taken with food.
The tablets may be swallowed with water. The tablets should be taken with a full glass of water.
The NEXIUM tablets are available in doses of 20 mg, 40 mg, and 80 mg.
The tablets should be swallowed with a full glass of water.
Stade de France Pharmacy